Rat model of the hypercalcaemia induced by parathyroid hormone-related protein: Characteristics of three bisphosphonates

European Journal of Pharmacology

Volumn 507, Issue 1-3, 2005, Pages 317-324

  Komatsu, Yoshimitsu ^a   Imai, Yohsuke ^a   Itoh, Fumiaki ^a   Kojima, Masami ^a   Isaji, Masayuki ^a   Shibata, Nobuo ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bisphosphonate; Hypercalcaemia; Renal dysfunction

Indexed keywords

CLODRONIC ACID; ETIDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERCALCEMIA; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY TUBULE; MALE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERCALCEMIA; MALE; PARATHYROID HORMONE-RELATED PROTEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 12344257762     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.11.050     Document Type: Article

References (31)

1. A.B. Abou-Samra, H. Jüppner, T. Force, M.W. Freeman, X.F. Kong, E. Schipani, P. Urena, J. Richards, J.V. Bonventre, J.T. Potts Jr., H.M. Kronenberg, and G.V. Segre Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium Proc. Natl. Acad. Sci. U. S. A. 89 1992 2732 2736
2. S. Adami, G. Salvagno, G. Guarrera, F. Montesanti, S. Garavelli, S. Rosini, and V. Lo Cascio Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate Calcif. Tissue Int. 39 1986 226 229
3. S. Adami, A.K. Bhalla, R. Dorizzi, F. Montesanti, S. Rosini, G. Salvagno, and V. Lo Cascio The acute-phase response after bisphosphonate administration Calcif. Tissue Int. 41 1987 326 331
4. G. Attardo-Parrinello, G. Merlini, F. Pavesi, F. Crema, M.L. Fiorentini, and E. Ascari Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis Arch. Intern. Med. 147 1987 1629 1633
5. A.E. Broadus, M. Mangin, K. Ikeda, K.L. Insogna, E.C. Weir, W.J. Burtis, and A.F. Stewart Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide N. Engl. J. Med. 319 1988 556 563
6. J.A. Danks, P.R. Ebeling, J. Hayman, S.T. Chou, J.M. Moseley, J. Dunlop, B.E. Kemp, and T.J. Martin Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin J. Bone Miner. Res. 4 1989 273 278
7. 3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion J. Bone Miner. Res. 15 2000 175 181
8. P. Filipponi, M. Pedetti, L. Fedeli, L. Cini, R. Palumbo, S. Boldrini, C. Massoni, and S. Cristallini Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy J. Bone Miner. Res. 10 1995 697 703
9. H. Fleisch Bisphosphonate-history and experimental basis Bone 8 Suppl. 1 1987 S23 S28
10. H.A. Fleisch, R.G.G. Russell, S. Bisaz, R.C. Mühlbauer, and D.A. Williams The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo Eur. J. Clin. Invest. 1 1970 12 18
11. H. Fleish Bisphosphonates in Bone Disease: From the Laboratory to the Patient 2nd Rev. ed. 1995 The Parthenon Publishing Group Lancs, UK
12. H.I.J. Harinck, S.E. Papapoulos, H.J. Blanksma, A.J. Moolenaar, P. Vermeij, and O.L.M. Bijvoet Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD) Br. Med. J. 295 1987 1301 1305
13. N. Horiuchi, M.P. Caulfield, J.E. Fisher, M.E. Goldman, R.L. McKee, J.E. Reagan, J.J. Levy, R.F. Nutt, S.B. Rodan, T.L. Schofield, T.L. Clemens, and M. Rosenblatt Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro Science 238 1987 1566 1568
14. N. Horiuchi, T. Hongo, and T.L. Clemens The synthetic human parathyroid hormone-related protein is inhibited by a parathyroid hormone antagonist in rats in vivo J. Bone Miner. Res. 5 1990 541 545
15. P. Jaeger, W. Jones, M. Kashgarian, R. Baron, T.L. Clemens, G.V. Segre, and J.P. Hayslett Animal model of primary hyperparathyroidism Am. J. Physiol. 252 1987 E790 E798
16. B.E. Kemp, J.M. Moseley, C.P. Rodda, P.R. Ebeling, R.E.H. Wettenhall, D. Stapleton, H. Diefenbach-Jagger, F. Ure, V.P. Michelangeli, H.A. Simmons, L.G. Raisz, and T.J. Martin Parathyroid hormone-related protein of malignancy: active synthetic fragments Science 238 1987 1568 1570
17. R. Kitazawa, Y. Imai, M. Fukase, and T. Fujita Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry Bone Miner. 12 1991 157 166
18. S. Kramer, F.H. Reynolds Jr., M. Castillo, D.M. Valenzuela, M. Thorikay, and J.M. Sorvillo Immunological identification and distribution of parathyroid hormone-like protein polypeptides in normal and malignant tissues Endocrinology 128 1991 1927 1937
19. P.J. Meunier, M.C. Chapuy, C. Alexandre, C. Bressot, C. Edouard, E. Vignon, L. Mathieu, and U. Trechsel Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone Lancet 2 1979 489 492
20. J.M. Moseley, J.A. Hayman, J.A. Danks, D. Alcorn, V. Grill, J. Southby, and M.A. Horton Immunohistochemical detection of parathyroid hormone-related protein in human fetal epithelia J. Clin. Endocrinol. Metab. 73 1991 478 484
21. G.R. Mundy Hypercalcemia of malignancy revisited J. Clin. Invest. 82 1988 1 6
22. J.J. Orloff, A.E. Ribaudo, R.L. McKee, M. Rosenblatt, and A.F. Stewart A pharmacological comparison of parathyroid hormone receptors in human bone and kidney Endocrinology 131 1992 1603 1611
23. A.D. Paterson, J.A. Kanis, E.C. Cameron, D.L. Douglas, D.J. Beard, F.E. Preston, and R.G.G. Russell The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma Br. J. Haematol. 54 1983 121 132
24. A.H.G. Paterson, T.J. Powles, J.A. Kanis, E. McCloskey, J. Hanson, and S. Ashley Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer J. Clin. Oncol. 11 1993 59 65
25. O.P. Purohit, C.R. Radstone, C. Anthony, J.A. Kanis, and R.E. Coleman A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy Br. J. Cancer 72 1995 1289 1293
26. S.H. Ralston, M.D. Gardner, F.J. Dryburgh, A.S. Jenkins, R.A. Cowan, and I.T. Boyle Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia Lancet 2 1985 907 910
27. R.R. Recker, G.S. Hassing, J.R. Lau, and P.D. Saville The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP™): renal handling of phosphorus and the renal response to parathyroid hormone J. Lab. Clin. Med. 81 1973 258 266
28. R. Rizzoli, J. Caverzasio, M.C. Chapuy, T.J. Martin, and J.P. Bonjour Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats J. Bone Miner. Res. 4 1989 759 765
29. R. Rizzoli, J. Caverzasio, F. Bauss, and J.-P. Bonjour Inhibition of bone resorption by the bisphosphonate BM21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein Bone 13 1992 321 325
30. M. Rossini, D. Gatti, N. Zamberlan, V. Braga, R. Dorizzi, and S. Adami Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis J. Bone Miner. Res. 9 1994 1833 1837
31. K. Takahashi, A. Shirahata, S. Fukushima, S. Kokubo, K. Teramura, and S. Usuda Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats Jpn. J. Pharmacol. 76 1998 155 163